News tagged with lung cells
Researchers find important 'target' playing role in tobacco-related lung cancers
Researchers at Moffitt Cancer Center in Tampa, Fla., have discovered that the immune response regulator IKBKE (serine/threonine kinase) plays two roles in tobacco-related non-small cell lung cancers. Tobacco carcinogens induce ...
Feb 09, 2012 |
5 / 5 (1) |
0
Metabolic profiles essential for personalizing cancer therapy
One way to tackle a tumor is to take aim at the metabolic reactions that fuel their growth. But a report in the February Cell Metabolism shows that one metabolism-targeted cancer therapy will not fit all. That means that m ...
Feb 07, 2012 |
4 / 5 (1) |
0
Combination drug therapy urged to battle lung cancer
Combination drug therapy may be needed to combat non-small cell lung cancer (NSCLC), according to a study by the Translational Genomics Research Institute (TGen) and Van Andel Research Institute (VARI).
Feb 02, 2012 |
not rated yet |
0
New research confirms need for lung cancer testing
Different kinds of lung cancer behave in different ways, suggesting they are fundamentally different diseases. According to a University of Colorado Cancer Center study published in Cancer, the official journal of the Am ...
Feb 02, 2012 |
4.5 / 5 (2) |
0
|
Lungs clothed in fresh cells offer new hope for transplant patients
For patients suffering from severe pulmonary diseases including emphysema, lung cancer or fibrosis, transplantation of healthy lung tissue may offer the best chance for survival. The surgical procedure, however, ...
Feb 01, 2012 |
not rated yet |
0
|
When the isolated lung runs out of air
A lung transplant is the only treatment option for patients faced with imminent pulmonary failure. But suitable donor organs are highly susceptible to damage in transit. A team of researchers based at LMU's Walther Straub ...
Feb 01, 2012 |
2 / 5 (1) |
0
New lung cancer test predicts survival
In the two largest clinical studies ever conducted on the molecular genetics of lung cancer, an international team led by scientists at the University of California, San Francisco (UCSF) has demonstrated that an available ...
Jan 26, 2012 |
4.8 / 5 (5) |
0
|
Study examines drug resistance in ALK positive lung cancer
Scientists from the University of Colorado Cancer Center have once again advanced the treatment of a specific kind of lung cancer. The team has documented how anaplastic lymphoma kinase (ALK) positive advanced non-small cell ...
Jan 19, 2012 |
not rated yet |
0
Mapping the destructive path from cigarette to emphysema
From the cherry red tip of a lighted cigarette through the respiratory tract to vital lung cells, the havoc created by tobacco smoke seems almost criminal, activating genes and portions of the immune system to create inflammation ...
Jan 18, 2012 |
5 / 5 (1) |
0
|
Ganetespib showed activity in KRAS-mutant NSCLC as monotherapy and in combinations
The investigational drug ganetespib, a synthetic second-generation Hsp90 inhibitor, slowed the growth of cancer cells taken from non-small cell lung cancer tumors with a mutation in the KRAS gene. The drug was even more active ...
Jan 11, 2012 |
not rated yet |
0
Sensitive detection method analyzes circulating tumor cells in patients with lung cancer
Researchers have developed a method to analyze circulating tumor cells in the blood of patients with non-small cell lung cancer. This method, which can analyze a sample size as small as three cells, may allow clinicians to ...
Jan 09, 2012 |
not rated yet |
0
Estrogen-targeting drug combo may help prevent lung cancer
A combination of drugs that target estrogen production significantly reduced the number of tobacco carcinogen-induced lung tumors in mice, according to results from a preclinical study.
Jan 09, 2012 |
not rated yet |
0
Scientists identify lung cancer stem cells and new drug targets
Singapore scientists, headed by Dr. Bing Lim, Associate Director of Cancer Stem Cell Biology at the Genome Institute of Singapore (GIS), a research institute under the umbrella of the Agency for Science, Technology and Research ...
Jan 06, 2012 |
not rated yet |
0
Plasmonic nanocrosses that heat up when illuminated can be used to kill cancer
Plasmonic nanoparticles are extremely sensitive to light, and even the tiniest amount can cause these particles to heat up. Scientists are now trying to use plasmonic nanoparticles in cancer therapy whereby ...
Nanotechnology / Bio & Medicine
Dec 23, 2011 |
5 / 5 (2) |
0
Cell membrane proteins could provide targets for broader vaccines
Vaccines with broader reach might be made by stimulating specialized immune cells to recognize foreign cell membrane proteins that are shared across bacterial species, say researchers from Children's Hospital of Pittsburgh ...
Dec 22, 2011 |
4.7 / 5 (3) |
0
|
